Statistical Experimental Designs for cLTB-Syn Vaccine Production Using Daucus carota Cell Suspension Cultures.

The carrot-made LTB-Syn antigen (cLTB-Syn) is a vaccine candidate against synucleinopathies based on carrot cells expressing the target antigen LTB and syn epitopes. Therefore, the development of an efficient production process is required with media culture optimization to increase the production y...

Descripción completa

Detalles Bibliográficos
Publicado en:Planta Medica Vol. 90; no. 10; pp. 744 - 757
Autores principales: Carreño-Campos, Christian, Villegas, Elba, Villarreal, María Luisa, Morales-Aguilar, Mónica, Govea-Alonso, Dania, Romero-Maldonado, Andrea, Jimenez-Capdeville, María E., Rosales-Mendoza, Sergio, Ortiz-Caltempa, Anabel
Formato: pictorial research tables/charts Journal Article
Publicado: Georg Thieme Verlag Stuttgart 2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178834116&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178834116
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00320943
        NH9
      jtl: Planta Medica
      issn: 00320943
      maglogo: N
    pubinfo:
      dt: 2024
      vid: 90
      iid: 10
      pid: 4536
      pub: Georg Thieme Verlag Stuttgart
    artinfo:
      ui:
        178834116
        178834116
        178834116
        10.1055/a-2307-0400
        178834116
      ppf: 744
      ppct: 13
      formats:
      tig:
        atl: Statistical Experimental Designs for cLTB-Syn Vaccine Production Using Daucus carota Cell Suspension Cultures.
      aug:
        au:
          Carreño-Campos, Christian
          Villegas, Elba
          Villarreal, María Luisa
          Morales-Aguilar, Mónica
          Govea-Alonso, Dania
          Romero-Maldonado, Andrea
          Jimenez-Capdeville, María E.
          Rosales-Mendoza, Sergio
          Ortiz-Caltempa, Anabel
        affil: Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México
      sug:
        subj:
          Synucleinopathies
          Carrot
          Cell Line Metabolism
          Urea
          Callus
          Tissue Culture Techniques Methods
          Culture Media
          Vaccines Immunology
          Parkinson Disease Prevention and Control
          Immunotherapy
          Animal Studies
          Mice
          Ecosystem
          Excitatory Amino Acid Agents
          Post Hoc Analysis
          Descriptive Statistics
          T-Tests
          Analysis of Variance
          Models, Statistical
          Gene Expression
          Proteins Analysis
          Cell Viability
          Genomics
          Immunization
          Plants, Medicinal
      ab: The carrot-made LTB-Syn antigen (cLTB-Syn) is a vaccine candidate against synucleinopathies based on carrot cells expressing the target antigen LTB and syn epitopes. Therefore, the development of an efficient production process is required with media culture optimization to increase the production yields as the main goal. In this study, the effect of two nitrogen sources (urea and glutamate) on callus cultures producing cLTB-Syn was studied, observing that the addition of 17 mM urea to MS medium favored the biomass yield. To optimize the MS media composition, the influence of seven medium components on biomass and cLTB-Syn production was first evaluated by a Plackett–Burman design (PBD). Then, three factors were further analyzed using a central composite design (CCD) and response surface methodology (RSM). The results showed a 1.2-fold improvement in biomass, and a 4.5-fold improvement in cLTB-Syn production was achieved at the shake-flask scale. At the bioreactor scale, there was a 1.5-fold increase in biomass and a 2.8-fold increase in cLTB-Syn yield compared with the standard MS medium. Moreover, the cLTB-Syn vaccine induced humoral responses in BALB/c mice subjected to either oral or subcutaneous immunization. Therefore, cLTB-Syn is a promising vaccine candidate that will aid in developing immunotherapeutic strategies to combat PD and other neurodegenerative diseases without the need for cold storage, making it a financially viable option for massive immunization.
      pubtype: Periodical
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N